Medcura Appoints Surgical Medical Device Leader Jim Buck as New CEO

Medcura, Inc., a commercial-stage life science and medical device company, has appointed James (Jim) Buck as Chief Executive Officer (CEO). A globally connected leader, Buck has been serving as Director at Medcura since 2018 and now fully steps into the CEO role with more than 25 years of highly relevant career experiences.

Lyniate Names Scott Galbari President

Integrated DNA Technologies, Beckman Coulter Life Sciences Ink Distribution Deal

Diurnal to present research into new treatments of Congenital Adrenal Hyperplasia (CAH) at ENDO 2022

Diurnal Group plc (AIM: DNL), will be presenting research findings on the treatment and management of congenital adrenal hyperplasia (CAH) at this year’s American Endocrine Society meeting, ENDO 2022, which will be taking place between 11-14 June 2022 in Atlanta, USA.

Abzena Selects IPS for Turnkey Delivery of New CGMP Facility in North Carolina

IPS to provide full design, construction management and CQV services for Abzena's new monoclonal antibody (mAb) facility in Sanford, North Carolina.

Absolute Antibody Expands Prometheus™ Antibody Humanization Service to Include Non-Murine Origin Species

MediKarma Selects 1upHealth as its Interoperability Partner to Help Patients Acquire Their Medical Records from Hospital EMRs

Bio-Rad Launches SEQuoia Express Stranded RNA Library Prep Kit at AGBT 2022

Bio-Rad Laboratories, Inc. (NYSE: BIO and BIOb), a global leader in life science research and clinical diagnostic products, today announced the launch of the SEQuoia Express Stranded RNA Library Prep Kit. The kit provides biopharmaceutical and research scientists with an easy-to-use solution for constructing robust libraries to support efficient RNA-Seq workflows for comprehensive transcriptome profiling. The SEQuoia Express Stranded RNA Library Prep Kit offers a cost-effective and automation-friendly solution to the current challenges in library generation. The kit enables researchers to construct robust libraries that capture mRNA and long noncoding RNA (>200 bp) transcripts for differential gene expression analysis and novel transcript discovery. Bio-Rad™ also provides a complementary and customized bioinformatics solution to streamline the full next-generation sequencing (NGS) workflow, from library preparation to data analysis.

DFE Pharma Appoints New Global HR Director to Further Invest in Team and Add Value

DFE Pharma Appoints New Global HR Director to Further Invest in Team and Add Value Goch, Germany (June 7th 2022) – DFE Pharma, a global leader in pharma-, biopharma-and nutraceutical excipient solutions, has appointed Marie-Louise Mans as Global Human Resources (HR) Director, joining as a member of the Leadership Team. DFE Pharma, headquartered in Goch, Germany, has facilities in 9 countries, employing around 450 people globally.

MDI Biological Laboratory Scientist Helping to Develop the Axolotl As a Model

Prayag Murawala, Ph.D., a scientist at the MDI Biological Laboratory in Bar Harbor, Maine, is leading the effort to establish the Mexican salamander, or axolotl, as a laboratory model for the study of regeneration. With the ability to regenerate almost any body part, the axolotl is nature’s champion of regeneration. The development of new tools to work with the axolotl is elevating it to the level of established research models and positioning the community of scientists who work with it for exponential growth. Many of the new tools developed for working with the axolotl, as well as those that are critically needed to expand the scope of axolotl research, are described by Murawala in two papers published in the June 2022 edition of the journal Developmental Dynamics.

Dotmatics Strengthens Leadership Team as it Continues to Invest in Organization Capabilities and Accelerate Growth

Dotmatics, the leader in R&D scientific software adds Chief Legal Officer and Chief People Officer

Antibody-drug Conjugates Manufacturing and Future Focus

ADCs demonstrated great potential for the treatment of cancers, and simultaneously require unique supporting infrastructure to meet biopharmaceutical industry standards for safe, effective, and reliable manufacturing.

Full-Scale Mitochondrial Bioenergetics Services at Creative Biogene

Creative Biogene provides partners with comprehensive range of mitochondrial bioenergetics detection and analysis services based on years of experience and high-end instruments.

Six-Peat: CTL Amedica's Sean Suh Recognized as a Top Spine Inventor

For the sixth year in a row, CTL Amedica CTO Sean Suh has been included in the Spinemarket Inc. Patent Analysis and Power Index, having been named to the current Top Twenty+ Inventors in Spine list. Suh has been included on the list every year, since its 2016 inception. This year, Suh is ranked number 13 on the list, with nine patents filed/cited in 2021 and 83 total from 2016-2021.

1upHealth Selected by NCQA As Partner in Digital Quality Solutions Pilot

MULTI-LEVEL, CLIA COMPLIANT CLINICAL REFERENCE MATERIALS FOR MICROPROTEIN TESTING AVAILABLE FROM VERICHEM LABORATORIES

Liquid stable and ready-to-use clinical reference materials for Microprotein testing are now available from VERICHEM LABORATORIES.

Patient centricity in drug innovation and packaging design to take centre stage at Connect in Pharma in Geneva this September

Connect in Pharma will highlight opportunities for the biopharmaceutical sector to reinvent packaging to be more focussed on patient needs. Oral medications are particularly ripe for a rethink, says speaker Tiffany McIntire, a Principal Systems Engineer at Roche.

Birmingham Biotech and Tanner Pharma Group enter distribution partnership for innovative nasal spray in Latin America

Birmingham Biotech Ltd, an innovator in diagnostic tests, protective nasal sprays and mobile medical facilities, and TannerLAC UK Limited ("TannerLAC"), a part of Tanner Pharma Group, have entered into a license agreement for the distribution of Norizite™ Nasal Spray in Latin America. TannerLAC provides pharmaceutical, biotech, and healthcare companies with a single-point partner for the commercialization of their products in challenging international markets.

CD Formulation Launches API Chemical Modification Services to Address Drug Solubility, Bioavailability, and Dissolution Rate Issues

Having abundant expertise in drug formulation and pharmaceutical preparation, the New York-based CRO company CD Formulation recently announces that it is now capable of conducting a wide range of API chemical modification services, including pH modification drug molecular service, drug salt formation service, drug pegylation service, and different groups of precursor drug design service, to help researchers address some of the long-standing issues in drug development like drug solubility, bioavailability, and dissolution rate.

The Healthcare Technology Report Names Andrea Kowalski on List of Top 25 Women in Healthcare IT in 2022

The Healthcare Technology Report has officially named Tebra’s Senior Vice-President of Product, Andrea Kowalski, to its list of Top 25 Women in Healthcare IT in 2022.